Deploying LLMs Safely in Clinical Settings

I have seen the same mistake enough times to call it a pattern: teams demo a clinical LLM on a clean prompt, then assume the production system will behave the same way when it meets messy chart history, partial context, duplicate terminology, and a provider who types like they are late for rounds. That assumption breaks fast. In clinical settings, the model is not the product. The workflow is the product, and the model is just one component inside it.

That matters because clinical risk does not show up only as a wrong answer. It shows up as a confident answer that bypasses review, a note that looks right but is unsupported, a suggestion that fits one payer policy and fails on another, or a triage summary that drops the one detail that should have changed the plan. If you deploy LLMs safely, you engineer for those failure modes up front.

My team has built enough live clinical software to know that safety is not a single gate. It is a stack. You start by deciding what the model is allowed to do, then you make it prove it can do that job under real-world mess. Only after that do you decide whether it can draft, assist, or act with narrow earned autonomy. Skip any of those steps and the rest does not hold.

The first decision is the one teams keep trying to avoid: what is the LLM actually for? If your answer is “documentation,” that is too broad. Documentation can mean summarizing a spoken encounter, suggesting structured fields, drafting a note, reconciling meds, coding support, or patient-facing instructions. Each one has different error tolerance, different evaluation criteria, and different blast radius.

I split clinical LLM use cases into four buckets:

• Low-risk drafting — internal summaries, inbox triage drafts, visit note scaffolds, handoff prep.
• Structured extraction — pulling problems, meds, allergies, orders, or prior auth facts from text into fields.
• Decision support — surfacing likely codes, guideline matches, or next-step suggestions for a clinician to accept or reject.
• Patient-impacting automation — anything that can trigger care, communication, or claims movement without a person reading it first.

The last bucket is where people get reckless. If the system can change what reaches a patient, payer, or clinician without review, then you have moved from assistant to operational actor. I do not ship that state on day one. At AST, when we work on clinical AI systems like Medexa, we keep the model anchored to the provider’s existing workflow and make every approval boundary explicit.

That is why I insist on traceability at the output layer. For any clinical draft, the system should show what source text the model actually used, what rule or policy it followed when available, and what parts are still human-verified. If you cannot map output back to source, you lose the ability to audit, debug, and defend it when something looks off.

Traceability also changes how your reviewers work. A physician does not want to reread a blob of AI prose. A coder does not want a generic confidence score. A compliance reviewer wants to see the exact evidence chain. The interface has to respect that. Otherwise the human becomes the fallback parser, and you have not reduced work — you have just moved it.

Now for the part teams underestimate: evaluation. Not benchmark theater. Real evaluation. You need a test set built from your actual workflow artifacts, with the ugly cases included. That means abbreviations, partial dictation, contradictory chart snippets, duplicate problems, vendor-specific phrasing, and all the weird edge cases your clinicians actually generate.

I build evaluations in layers:

1. Freeze the workflow slice Pick one narrow task, such as visit summarization, ICD-10 suggestion, prior auth extraction, or inbox draft generation. Do not mix use cases while you are still proving safety.
2. Assemble a gold set Use real de-identified examples that reflect the live distribution. Include messy inputs, not just polished charts.
3. Define failure classes Track omission, hallucination, wrong attribution, unsafe recommendation, brittle formatting, overgeneration, and policy mismatch separately. One aggregate score hides too much.
4. Run human review against source Reviewers should compare model output to source text and workflow policy, not to their memory of what “sounds right.”
5. Test regression on every change A prompt tweak, model swap, retrieval change, or clinic-specific rule update can move the error profile. Re-run the suite every time.

The counterintuitive thing I learned the hard way: the model that sounds better in a demo is often worse in production. Why? Because polished language can hide factual drift. A terse output with explicit citations is usually safer than a beautiful paragraph that reads like progress but contains no audit trail.

That is especially true in ambient or note-generation workflows. A clinical note must not just be readable; it must be grounded. If the model pads missing detail with plausible filler, the note becomes more dangerous than a bad template because humans trust it more. You need hard controls that force the model to say “not present” or leave a field blank when the source does not support an assertion.

Guardrails that actually work are mostly boring engineering. They are not magical policy prompts. They are request filters, retrieval boundaries, output validators, and role-specific permissions. Here is the stack I trust:

• Input scoping — only give the model the minimum patient context needed for the task.
• Retrieval boundaries — if you use RAG, restrict it to approved clinical sources and the specific chart objects relevant to the task.
• Output schema enforcement — require structured output where possible, then validate it before anything downstream reads it.
• Deterministic rule checks — use rules for things that should not be probabilistic, such as required fields, policy matches, unsafe combinations, or missing attestations.
• Escalation paths — define exactly when the system stops and asks for a human, rather than guessing.

Two things fail here over and over. First, teams trust the model to self-police on missing context. It will not. Second, teams try to solve every problem with the prompt. That is the wrong layer. Prompts are brittle. Controls are durable.

If you are operating in a regulated environment, you also need model version control with release discipline. I do not mean a vague tag in a notebook. I mean you can tell which model, prompt, retrieval corpus, ruleset, and UI flow produced a given output on a given day. Without that, incident review turns into folklore.

This is where the cloud and application side meet. If the system is serving clinician workflows, you need logs that are useful without leaking protected data, retention rules that support audit, and access controls that reflect real operational roles. In one of our AST implementations, the biggest debugging win came from being able to line up prompt version, source document set, and reviewer action in the same trace. Without that, we would have argued about the symptom instead of fixing the cause.

There is also a trust model problem that most product teams never name. They launch one behavior for everyone and call it consistency. That is not how clinical deployment should work. Trust should be earned per task and per user group. A model can be good at med summarization and still be bad at patient instructions. It can be acceptable for a coder review flow and unacceptable for autonomous outbound communication.

I like a staged rollout:

1. Shadow mode The model makes its decision silently. Humans do the real work. We measure agreement, error types, and throughput impact.
2. Assist mode The model drafts or suggests, but a human approves every item before it moves forward.
3. Narrow autonomy Only for routine, low-risk, high-consensus tasks with explicit rules and rollback paths.
4. Continuous monitoring Re-check drift, reviewer override rates, and edge-case failures after launch, not just during it.

That sequence is not conservative theater. It is how you keep one bad behavior from contaminating the entire workflow. We have used this approach in live implementation work because the alternative is to discover the failure in front of a clinician, or worse, after a patient-facing artifact has already gone out.

If you are building on top of an existing EMR or HIS, keep the LLM outside the system of record at first. Let it assist, draft, or classify, but do not make it the place where truth lives. The record system, the rules engine, and the approval flow need to stay deterministic. The model should sit on top, not inside, your source of truth.

For teams trying to decide whether to build, buy, or partner, I use a simple comparison. Each option can work, but they fail in different places.

The common thread is simple: none of these options removes your responsibility. If the model touches a clinical workflow, you own the governance and the consequence. A vendor can help you build the scaffolding, but they cannot inherit your risk posture.

At AST, we learned that the fastest way to derail a safe rollout is to let product enthusiasm outrun clinical operations. A shiny demo creates pressure to go live. But if the downstream review path is not ready, if the audit logs are incomplete, or if the system cannot explain itself, you do not have a deployable system. You have a liability with a UI.

What should you do this week? Pick one workflow and put it on a safety rail. Do not treat this as a full platform redesign. Treat it as a focused deployment review.

1. Choose one workflow Pick one narrow use case with clear reviewers and a clear downstream action.
2. Document the unsafe outcomes List what would count as unacceptable: hallucinated facts, wrong attribution, missing source support, or unauthorized action.
3. Build the review boundary Decide exactly what must be human-approved before anything leaves the system.
4. Create a small gold set Use real examples from your environment and include the messiest cases.
5. Instrument the trace Make sure you can recover source, version, reviewer, and rule path for every output.
6. Launch in shadow or assist mode Measure what the model does before you let it influence care-facing output.

That is where safe deployment starts. Not with a grand AI strategy deck. With one workflow, one measurable boundary, and one system that can explain itself under pressure.

I am opinionated about this because I have seen the opposite approach waste months. Teams get attached to general-purpose intelligence and forget that clinical software survives on specificity. If the model cannot be pinned to a task, validated against real chart artifacts, and fenced with deterministic checks, it does not belong in production.